National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

bcr-abl peptide vaccine
A multivalent antineoplastic vaccine comprised of the bcr-abl oncogene breakpoint fusion peptide that elicits a bcr-abl specific T-cell immune response. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:bcr-abl vaccine



Previous:BB-10901, BCG vaccine, bcr-abl (b2a2)-derived peptide vaccine, bcr-abl (b3a2)-derived peptide vaccine, bcr-abl p210-b3a2 breakpoint-derived multipeptide vaccine
Next:BEACOPP regimen, Bead Block Compressible Microspheres, becatecarin, Becenum, beclomethasone dipropionate

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov